Literature DB >> 19539041

Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.

Helen Prior1, Nick McMahon, Jason Schofield, Jean-Pierre Valentin.   

Abstract

INTRODUCTION: The primary objective of this investigation was to evaluate the sensitivity of a non-invasive telemetry system for the detection of drug-induced electrocardiogram (ECG) changes in conscious, freely moving dogs. A secondary objective was to compare, in the same set of dogs, ECG data acquired by a non-invasive system with data acquired from a surgically implanted telemetry device (invasive system).
METHODS: Continuous beat-to-beat Lead II ECG data were simultaneously acquired from 6 male dogs using a non-invasive and an invasive telemetry system for 1h pre-dose and 6h following a sham control dose or single oral doses of (+/-) sotalol (4, 8 or 16 mg/kg). ECG parameters of heart rate, RR, PQ, QRS, QT and QT corrected for heart rate according to Van de Water (QTcV) and by an individual linear regression formula (QTcR), were determined. RESULTS AND DISCUSSION: Statistically significant dose-dependent reduction of heart rate, and increases in PQ, QT and QTc (V and R) were detected at all dose levels of (+/-) sotalol, with partial recovery during the 6-hour monitoring period. Statistically significant correlations for heart rate, RR, PQ, QT and QTc (V and R) were found between the two systems. QRS duration did not correlate. However, the difference between the two systems was consistent over the range studied. Based on these findings, the non-invasive system is quantitatively comparable to invasive telemetry, and can be used successfully to acquire continuous ECG data on a beat-to-beat basis from conscious freely moving dogs for at least 6h post-dose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539041     DOI: 10.1016/j.vascn.2009.06.001

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  12 in total

1.  Model-based evaluation of drug-induced QTc prolongation for compounds in early development.

Authors:  Vincent F S Dubois; Huixin Yu; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  Smart undershirt.

Authors:  Teresa Woodger
Journal:  Lab Anim (NY)       Date:  2017-10-06       Impact factor: 12.625

3.  A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation.

Authors:  S Y A Cheung; J Parkinson; U Wählby-Hamrén; C D Dota; Å M Kragh; L Bergenholm; T Vik; T Collins; C Arfvidsson; C E Pollard; H K Tomkinson; B Hamrén
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-05-07       Impact factor: 2.745

4.  Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.

Authors:  Raja Venkatasubramanian; Teresa A Collins; Lawrence J Lesko; Jerome T Mettetal; Mirjam N Trame
Journal:  Br J Pharmacol       Date:  2020-06-18       Impact factor: 8.739

5.  Effect of Wearing a Telemetry Jacket on Behavioral and Physiologic Parameters of Dogs in the Open-Field Test.

Authors:  Richard E Fish; Melanie L Foster; Margaret E Gruen; Barbara L Sherman; Davidc C Dorman
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

6.  Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.

Authors:  V F S Dubois; E Casarotto; M Danhof; O Della Pasqua
Journal:  Br J Pharmacol       Date:  2016-09-07       Impact factor: 8.739

7.  Predicting QRS and PR interval prolongations in humans using nonclinical data.

Authors:  L Bergenholm; J Parkinson; J Mettetal; N D Evans; M J Chappell; T Collins
Journal:  Br J Pharmacol       Date:  2017-08-24       Impact factor: 8.739

8.  Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.

Authors:  K Derakhchan; R W Chui; D Stevens; W Gu; H M Vargas
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  Opportunities to Apply the 3Rs in Safety Assessment Programs.

Authors:  Fiona Sewell; Joanna Edwards; Helen Prior; Sally Robinson
Journal:  ILAR J       Date:  2016-12

10.  Social housing of non-rodents during cardiovascular recordings in safety pharmacology and toxicology studies.

Authors:  Helen Prior; Anna Bottomley; Pascal Champéroux; Jason Cordes; Eric Delpy; Noel Dybdal; Nick Edmunds; Mike Engwall; Mike Foley; Michael Hoffmann; Robert Kaiser; Ken Meecham; Stéphane Milano; Aileen Milne; Rick Nelson; Brian Roche; Jean-Pierre Valentin; Gemma Ward; Kathryn Chapman
Journal:  J Pharmacol Toxicol Methods       Date:  2016-03-31       Impact factor: 1.950

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.